These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 1697373

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Combination of nifedipine and doxazosin in essential hypertension.
    Donnelly R, Elliott HL, Meredith PA, Howie CA, Reid JL.
    J Cardiovasc Pharmacol; 1992 Apr; 19(4):479-86. PubMed ID: 1380588
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Concentration-effect relationships and individual responses to doxazosin in essential hypertension.
    Donnelly R, Elliott HL, Meredith PA, Reid JL.
    Br J Clin Pharmacol; 1989 Nov; 28(5):517-26. PubMed ID: 2531605
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM.
    Chan JC, Nicholls MG, Cheung CK, Law LK, Swaminathan R, Cockram CS.
    Diabetes Care; 1995 Jul; 18(7):1001-6. PubMed ID: 7555530
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Renin-angiotensin system in two genetically normotensive strains of Lyon rats.
    Lantelme P, Lo M, Sassard J.
    Am J Hypertens; 2000 Mar; 13(3):283-9. PubMed ID: 10777033
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antihypertensive effects and pharmacokinetics of single and consecutive administration of doxazosin in patients with mild to moderate essential hypertension.
    Shionoiri H, Yasuda G, Yoshimura H, Umemura S, Miyajima E, Miyakawa T, Takagi N, Kaneko Y.
    J Cardiovasc Pharmacol; 1987 Jul; 10(1):90-5. PubMed ID: 2441160
    [Abstract] [Full Text] [Related]

  • 14. A single-blind study of doxazosin in the treatment of essential hypertension when added to nonresponders to angiotensin-converting enzyme inhibitor therapy.
    Englert RG, Mauersberger H.
    Am Heart J; 1988 Dec; 116(6 Pt 2):1826-32. PubMed ID: 2904758
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of the effects of angiotensin II, losartan, and enalapril on baroreflex control of heart rate in conscious rabbits.
    Weinstock M, Gorodetsky E.
    J Cardiovasc Pharmacol; 1995 Mar; 25(3):501-7. PubMed ID: 7769820
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dose-response clarification in early drug development.
    Meredith PA, Elliott HL, Donnelly R, Reid JL.
    J Hypertens Suppl; 1991 Dec; 9(6):S356-7. PubMed ID: 1840197
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.